Crescent Diagnostics Announces Positive Clinical Results for its Novel Bone Quality Test, BQT(TM)

LONDON, UK – June 8 (SEND2PRESS NEWSWIRE) — Crescent Diagnostics Ltd (‘Crescent’), today announced the publication of a recent study demonstrating the potential of the Bone Quality Test, BQT(TM) to diagnose osteoporosis. More women at risk can be screened with an accurate, simple to use test which does not require a hospital visit.